Document:

Officers' Certificate pursuant to Section 301

 Exhibit 4.2 
  

HEALTH CARE PROPERTY INVESTORS, INC. 
  
 Officers’ Certificate 
  
 August 27, 2004 
  
 We, Mark Wallace and Edward J. Henning, do hereby certify that we are the duly elected Senior Vice President and Chief Financial Officer, and Senior Vice President, General Counsel and Corporate Secretary,
respectively, of Health Care Property Investors, Inc., a Maryland corporation (the “Company”). We further certify that, pursuant to resolutions of the Board of Directors of the Company, duly adopted by unanimous written consent in lieu of
a meeting on December 10, 2003 and at a meeting of the Board of Directors on July 22, 2004 and attached hereto as Exhibit A-1, a series of Securities of the Company shall be established pursuant to Section 301 of the Indenture dated as of September
1, 1993 (the “Indenture”) between the Company and The Bank of New York, as trustee. We further certify that, pursuant to resolutions of the Board of Directors of the Company, duly adopted at a meeting on July 22, 2004 and attached hereto
as Exhibit A-1, the aggregate initial offering price of the Notes of said series shall be $200,000,000; and that said series shall have the following terms and provisions: 
  
 (i) the title of such series of Securities shall be “Medium-Term Notes, Series F” (referred to
herein as the “Notes”); 
  
 (ii)
subject to being increased by the Company pursuant to a subsequent Officers’ Certificate, the Notes which may be authenticated and delivered under the Indenture shall be limited to $200,000,000 aggregate initial offering price (except for Notes
authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of, other Notes pursuant to Section 304, 305, 306, 906 or 1107 of the Indenture); 
  
 (iii) the Notes shall be issuable as Registered Securities only, without coupons, in denominations of $1,000
or in any amount in excess thereof which is an integral multiple of $1,000; 
  
 (iv) unless otherwise specified by any Chairman, President, Chief Executive Officer, Chief Financial Officer or any Executive Vice President or Senior Vice President of the Company (the “Designated
Officers”) and set forth in the applicable Note, Notes issued in the form of permanent global certificates shall be dated the date of their issuance; 
  
 (v) the principal amount of each Note shall be determined by any one of the Designated Officers and shall be set forth in the applicable
Note; 
  
 (vi) the date on which the principal of
each of the Notes shall be payable shall be a Business Day nine months or more from the date of issuance as selected by the Purchaser and agreed to by the Company, as determined by either of the Designated Officers and set forth in the applicable
Note; 
  

 (vii) the rate or rates at which each of the Notes shall bear interest shall be
established by the Company as determined by any of the Designated Officers and set forth in the applicable Note, and may be either a fixed interest rate or may vary from time to time in accordance with one or more interest rate formulas; 

 
 (viii) the Interest Payment Dates and the Regular Record
Dates with respect to each Note shall be specified by the Company as determined by any of the Designated Officers and set forth in the applicable Note; 
  
 (ix) interest on each Note shall be calculated on the basis specified by the Company with respect to such Note as determined by any of the
Designated Officers and set forth in the applicable Note; 
  
 (x) no Additional Amounts shall be paid in respect of the Notes; 
  
 (xi) principal and interest payable with respect to the Notes shall be payable, Notes may be surrendered for registration of transfer and
exchange, and notices or demands to or upon the Company in respect of the Notes and the Indenture may be served, at the Corporate Trust Office of The Bank of New York, located at 101 Barclay Street-21W, New York, New York 10286; 
  
 (xii) if provided on the face of a Note, such Note may,
prior to its Stated Maturity, be subject to redemption, in whole or in part, at the option of the Company or be subject to repayment, in whole or in part, at the option of the Holder or both; the Company shall specify, as determined by any of the
Designated Officers and set forth in the applicable Note, the period or periods within which, the price or prices at which and the other terms and conditions upon which such Notes may be redeemed and/or repaid, if any; 
  
 (xiii) unless otherwise specified by the Company in a
subsequent Officers’ Certificate, the Notes will not be subject to any sinking fund; 
  
 (xiv) unless specified by the Company as determined by any of the Designated Officers and set forth in the applicable Note, the Notes
shall be issued in the form of one or more Book-Entry Securities, and the Depositary for such Notes shall be The Depository Trust Company or its nominee, and the beneficial owners of interests in any such Book-Entry Securities may not exchange any
such interests (except as provided by Section 305 of the Indenture); 
  
 (xv) if other than the principal amount of any Note is to be paid upon the declaration of acceleration of the Maturity of any Note pursuant to Section 502 of the Indenture, such amount shall be specified by the
Company, as determined by any of the Designated Officers and set forth in the applicable Note; 
  
 (xvi) if specified by the Company as determined by any of the Designated Officers and set forth in the applicable Note, the amount of
payments of principal of and any premium or interest on the Notes may be determined with reference to an index, formula or other method or methods; the Company shall specify, as determined by any of 

  

 
the Designated Officers and set forth in the applicable Note, the terms and conditions upon which and the manner in which such amounts shall be determined
and paid or payable; 
  
 (xvii) there are no
deletions from, modifications of or additions to the Events of Default or covenants of the Company with respect to the Notes; 
  
 (xviii) The Bank of New York shall act as Trustee with respect to the Notes; 
  
 (xix) any other terms with respect to the Notes may be
specified by the Company as determined by any of the Designated Officers and set forth in the applicable Note; 
  
 (xx) the Notes may have such other terms as are provided in the forms of certificate used to evidence the Notes approved in an
Officers’ Certificate of the Company, dated as of the date hereof, pursuant to Section 201 of the Indenture; 
  
 (xxi) Each Designated Officer is hereby authorized to communicate, from time to time through the use of facsimile transmission or by
telephone (immediately confirmed in writing at any time on the same date), the foregoing terms of any Note and any other instructions related thereto to the Trustee or any authenticating agent or paying agent regarding the completion and delivery of
such Note; 
  
 (xxii) The Trustee and any
authenticating agent and paying agent shall be entitled to rely on the information provided to it or them in accordance with the foregoing paragraphs until such time as the Trustee and such authenticating agent and paying agent receive a subsequent
certificate from the Company deleting or amending any of the information set forth therein; and 
  
 (xxiii) The Notes, when completed as contemplated by the foregoing paragraphs, will set forth the terms required to be set forth in this
certificate pursuant to Section 301 of the Indenture, and said terms are incorporated herein by reference. 
  
 We further certify, having read the Indenture, including Sections 303 and 501 thereof, and the definitions in the Indenture relating thereto and certain
other corporate documents and records, and having made such examination or investigation as we deemed necessary to enable us to express an informed opinion, that all conditions precedent to the authentication and delivery of the Notes have been
complied with and, to the best of our knowledge, no event which is, or after notice or lapse of time would become, an Event of Default with respect to any of the Securities has occurred and is continuing. 
  
 Capitalized terms used herein that are not otherwise defined shall have the
meanings ascribed thereto in the Indenture. 
  
 [SIGNATURE PAGE
FOLLOWS] 
  

 IN WITNESS WHEREOF, the undersigned have executed this Officers’ Certificate as of the date first
written above. 
  

			
		
	By:	 	 /s/ Mark Wallace

	 	 	 Mark Wallace
 Senior Vice President and Chief Financial Officer

		
	By:	 	 /s/ Edward J. Henning

	 	 	 Edward J. Henning
 Senior Vice President, General Counsel
 and Corporate SecretaryForm of Fixed Rate Medium-Term Note

 Exhibit 4.3 
  

FIXED RATE GLOBAL MEDIUM-TERM NOTE 
  
 The following legend is for inclusion only in Book-Entry Securities for which The Depository Trust Company serves as Depositary — Unless this
certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation (“DTC”), to the Company or its agent for registration of transfer, exchange or payment, and any certificate issued is
registered in the name of Cede & Co. or in such other name as is requested by an authorized representative of DTC and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative of DTC, any
transfer, pledge or other use hereof for value or otherwise by or to any Person is wrongful inasmuch as the registered owner hereof, Cede & Co., has an interest herein. 
  
 The following legend is for inclusion only in Book-Entry Securities — UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN
PART FOR NOTES IN CERTIFICATED FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR
ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. 
  

					
	 REGISTERED
	  	 	  	PRINCIPAL AMOUNT
	 No. FXR-1
	  	CUSIP NO. 42217J	  	$                            

  
 HEALTH CARE PROPERTY
INVESTORS, INC. 
 MEDIUM-TERM NOTE, SERIES F 
 (FIXED RATE) 
  

							
	ORIGINAL ISSUE DATE:	  	INTEREST RATE:	  	STATED MATURITY DATE:	  	 

  
 INTEREST PAYMENT DATES: 
  

							
	INITIAL REDEMPTION DATE:	  	 INITIAL REDEMPTION
 PERCENTAGE:
	  	 ANNUAL REDEMPTION
 PERCENTAGE REDUCTION:
	  	 

  
 OPTIONAL REPAYMENT DATE(S):

  

					
	 DAY COUNT CONVENTION
	  	 	  	 
	 ̈ 30/360 FOR THE PERIOD FROM	  	 TO
	  	 
	 ̈ ACTUAL/360 FOR THE PERIOD FROM	  	 TO
	  	 
	 ̈ ACTUAL/ACTUAL FOR THE PERIOD FROM	  	 TO
	  	 
			
	ADDENDUM ATTACHED:	  	ORIGINAL ISSUE DISCOUNT:	  	 
	x Yes	  	 ̈ Yes	  	 
	 ̈ No	  	 ̈ No	  	 
	 	  	Total Amount of OID:	  	 
	 	  	Yield to Maturity:	  	 
	 	  	Initial Accrual Period:	  	 

  
 OTHER
PROVISIONS: 
  
 Each time the Company files a Pricing Supplement
with the Securities and Exchange Commission, the Pricing Supplement will govern the terms of the issuance of the Securities and the first two pages of this Fixed Rate Global Medium-Term Note will be completed bearing the nine-digit CUSIP Number and
the principal amount issued. Such Pricing Supplement will be attached to this Fixed Rate Global Medium-Term Note. 
  

 2 

 HEALTH CARE PROPERTY INVESTORS, INC., a Maryland corporation (“Issuer” or the
“Company,” which terms include any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the Principal Amount specified above on the Stated
Maturity Date specified above (except to the extent redeemed or repaid prior to the Stated Maturity Date), and to pay interest thereon at the Interest Rate per annum specified above, until such Principal Amount is paid or duly made available for
payment. Reference herein to “this Note,” “hereof,” “herein” and comparable terms shall include an Addendum hereto if an Addendum is specified above. 
  
 The Company will pay interest on each Interest Payment Date specified above, commencing on the first Interest Payment Date
specified above next succeeding the Original Issue Date specified above, and on the Stated Maturity Date or any Redemption Date or Optional Repayment Date (the date of each such Stated Maturity Date, Redemption Date and Optional Repayment Date and
the date on which principal or an installment of principal is due and payable by declaration of acceleration pursuant to the Indenture being referred to hereinafter as a “Maturity” with respect to principal payable on such date);
provided, however, that if the Original Issue Date is between a record date (as defined below) and the next succeeding Interest Payment Date, interest payments will commence on the Interest Payment Date immediately following the next
succeeding record date to the registered Holder on such next succeeding record date. Except as provided above, interest payments will be made on the Interest Payment Dates shown above. Unless otherwise specified above, the “record date”
shall be the date 15 calendar days (whether or not a Business Day) immediately preceding the applicable Interest Payment Date. Interest on this Note will accrue from and including the most recent Interest Payment Date to which interest has been paid
or duly provided for or, if no interest has been paid, from the Original Issue Date specified above, to, but excluding such Interest Payment Date, as the case may be. If the Maturity or an Interest Payment Date falls on a day which is not a Business
Day as defined below, the payment due on such Maturity or Interest Payment Date will be paid on the next succeeding Business Day with the same force and effect as if made on such Maturity or Interest Payment Date, as the case may be, and no interest
shall accrue with respect to such payment for the period from and after such Maturity or Interest Payment Date. The interest so payable and punctually paid or duly provided for on any Interest Payment Date will as provided in the Indenture be paid
to the Person in whose name this Note is registered at the close of business on the record date for such Interest Payment Date. Any such interest which is payable, but not punctually paid or duly provided for on any Interest Payment Date (herein
called “Defaulted Interest”), shall forthwith cease to be payable to the registered Holder on such record date, and may be paid to the Person in whose name this Note is registered at the close of business on a Special Record Date (which
shall be not more than 15 nor less than ten days prior to the date of payment of such Defaulted Interest) established by notice given by mail by or on behalf of the Company to the Holder of this Note not less than ten days preceding such Special
Record Date, all as more fully provided in the Indenture. 
  
 Payment of interest on this Note will be made at the office or agency of the Company maintained by the Company for such purpose in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as
at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the Company, payment of interest due other than at Maturity may be made by check mailed to the address of the
Person entitled thereto as such address shall appear in the registry books of the 

  

 3 

 
Company; and provided, further, that the payment of the principal of and interest on this Note on any Optional Repayment Date(s), if any,
indicated above shall be made upon satisfaction of the provisions herein; and provided, further, that AT THE OPTION OF THE COMPANY, the Holder of Notes with an aggregate principal amount of $10,000,000 or more will be entitled to
receive payments of interest on this Note (other than at Maturity) by wire transfer of immediately available funds if appropriate wire transfer instructions have been received in writing by the Trustee (as defined below) not less than 15 days prior
to the applicable Interest Payment Date. Such wire instructions, upon receipt by the Trustee, shall remain in effect until revoked by such Holder. 
  
 Payment of principal or premium, if any, at the Maturity of this Note will be made in immediately available funds upon presentation of this Note at the
office or agency of the Company maintained by the Company for such purpose in the Borough of Manhattan, The City of New York, or at such other place as the Company may designate. Payment of interest due at Maturity will be made to the person to whom
payment of the principal of this Note shall be made. 
  
 Unless
the certificate of authentication hereon has been executed by or on behalf of the Trustee under the Indenture, by the manual signature of one of its authorized signatories, this Note shall not be entitled to any benefit under the Indenture or be
valid or obligatory for any purpose. 
  
 This Note is one of a
duly authorized series of Securities (hereinafter called the “Securities”) of the Company designated as its Medium-Term Notes, Series F (the “Notes”). The Notes are issued and to be issued under an Indenture dated as of September
1, 1993 (herein called the “Indenture”) between the Company and The Bank of New York, a corporation incorporated under the laws of the State of New York, as trustee (the “Trustee,” which term includes any successor trustee with
respect to the Notes under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, duties and obligations thereunder of the Company, the Trustee and the Holders of
the Notes and the terms upon which the Notes are to be authenticated and delivered. The terms of individual Notes may vary with respect to interest rates or interest rate formulas, issue dates, maturity, redemption, repayment and otherwise. The
Notes may be issued from time to time in an aggregate initial offering price up to $200,000,000, which amount may be increased if duly authorized by the Company. 
  
 Except as otherwise provided in the Indenture, this Note will be issued in global form only registered in the name of the
Depositary or its nominee. This Note will not be issued in definitive form, except as otherwise provided in the Indenture, and ownership of this Note shall be maintained in book-entry form by the Depositary for the accounts of participating
organizations of the Depositary. 
  
 Unless otherwise provided
above and in accordance with the provisions herein, this Note is not subject to any sinking fund and is not redeemable or repayable prior to the Stated Maturity Date. 
  

 4 

 If so provided above, this Note may be redeemed by the Company on any date on and after the Initial
Redemption Date, if any, specified above. If no Initial Redemption Date is set forth above, this Note may not be redeemed prior to the Stated Maturity Date. On and after the Initial Redemption Date, if any, this Note may be redeemed at any time in
whole or from time to time in part in increments of $1,000 (provided that any remaining principal hereof shall be at least $1,000) at the option of the Company at the applicable Redemption Price (as defined below) together with accrued interest
hereon at the applicable rate payable to the date of redemption (each such date, a “Redemption Date”), on written notice to the Holder hereof given not more than 60 nor less than 30 days prior to the Redemption Date and in accordance with
the provisions of the Indenture. In the event of redemption of this Note in part only, a new Note for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the surrender hereof. 
  
 Unless otherwise specified above, the “Redemption Price” shall
initially be the Initial Redemption Percentage, specified above, of the principal amount of this Note to be redeemed and shall decline at each anniversary of the Initial Redemption Date, shown above, by the Annual Redemption Percentage Reduction, if
any, specified above, of the principal amount to be redeemed until the Redemption Price is 100% of such principal amount. 
  
 This Note may be subject to repayment at the option of the Holder on any Optional Repayment Date(s), if any, indicated above. If no Optional Repayment
Date(s) are set forth above, this Note may not be so repaid at the option of the Holder hereof prior to the Stated Maturity Date. On any Optional Repayment Date, this Note shall be repayable in whole or in part in increments of $1,000 (provided that
any remaining principal hereof shall be at least $1,000) at the option of the Holder hereof at a repayment price, unless otherwise specified above, equal to 100% of the principal amount to be repaid, together with interest thereon payable to the
date of repayment. For this Note to be repaid in whole or in part at the option of the Holder hereof, this Note must be received, with the form entitled “Option to Elect Repayment” below duly completed, by the Trustee at its Corporate
Trust Office, or such other address of which the Company shall from time to time notify the Holders of the Notes, not more than 60 nor less than 30 days prior to the related Optional Repayment Date. Exercise of such repayment option by the Holder
hereof shall be irrevocable. With respect to Notes represented by global securities, any option for repayment may be exercised by the Depositary, on behalf of the owners of the beneficial interest in the Notes represented by such global securities,
by delivering a written notice substantially similar to the above-referenced form, duly completed, to the Trustee at the place and within the time period described above. All such notices shall be irrevocable. 
  
 Interest payments on this Note shall include interest accrued from, and
including, the Original Issue Date indicated above, or the most recent date to which interest has been paid or duly provided for, to, but excluding, the related Interest Payment Date or Maturity, as the case may be, until the Principal Amount is
paid or made available for payment. Unless otherwise specified on the first page of this Note, interest payments for this Note shall be computed and paid on the basis of a 360-day year of twelve 30-day months. 
  
 As used herein, “Business Day” means, unless otherwise specified
above, any day, other than Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions 

  

 5 

 
are authorized or required by law, regulation or executive order to close in The City of New York. 
  
 Any provision contained herein with respect to the calculation of the rate of
interest applicable to this Note, its payment dates or any other matter relating hereto may be modified as specified in an Addendum relating hereto if so specified above. 
  
 The Notes shall have the Events of Default as set forth in Section 501 of the Indenture. If an Event of Default with respect
to the Notes shall occur and be continuing, the principal of all the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
  
 The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights
and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of 66 2/3% in aggregate principal amount of
the Outstanding Securities of each series affected thereby. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the Securities of each series at the time Outstanding, on behalf of
the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note
shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof whether or not notation of such consent or waiver is
made upon this Note. 
  
 This Note is subject to satisfaction,
discharge and defeasance as provided in Article Four of the Indenture. 
  
 No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this
Note at the time, place and rate, and in the coin or currency herein prescribed. 
  
 The Indenture imposes certain limitations on the ability of the Company to incur indebtedness and consolidate, merge or transfer all or substantially all of the Company’s assets. These limitations are subject to
certain qualifications and exceptions, and reference is made to the Indenture for a description thereof. 
  
 As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note may be registered on the registry books of
the Company, upon surrender of this Note for registration of transfer at the office or agency of the Company maintained by the Company for such purpose in the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written
instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder hereof or by its attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate
principal amount, having the identical Original Issue Date, Stated Maturity and provisions with 

  

 6 

 
respect to payment of interest and redemption or repayment prior to Stated Maturity will be issued to the designated transferee or transferees. 

 
 The Notes are issuable only in registered form without coupons in
denominations of $1,000 and integral multiples thereof. As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes as requested by the Holder
surrendering the same. 
  
 No service charge shall be made by the
Company or the Trustee for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection therewith (other than exchanges
pursuant to the Indenture not involving any transfer). 
  
 Prior
to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this
Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
  
 If money for the payment of principal or interest remains unclaimed for three years, the Trustee or any paying agent will pay the money back to the
Company at its request. After any such payment, Holders entitled to the money, as an unsecured creditor, must look to the Company for payment and all liability of the Trustee or such paying agent with respect to such money shall cease. 

 
 The terms of this Note include those stated in the Indenture and those
made part of the Indenture by the Officers’ Certificate delivered pursuant thereto and the Trust Indenture Act. This Note is subject to all such terms, and Noteholders are referred to the Indenture and said Act for a statement of them.

  
 No stockholder, director, officer, employee or incorporator as
such, past, present or future, of the Company or any successor corporation shall have any liability for any obligations of the Company under this Note or the Indenture or for any claim based on, or in respect of or by reason of, such obligations or
their creation. Each holder of a Note by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for the issue of this Note. 
  
 The Trustee under the Indenture, in its individual or any other capacity, may deal with the Company as if it were not
Trustee. 
  
 This Note shall be governed by and construed in
accordance with the laws of the State of California. 
  
 All terms
used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. 
  

 7 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed, manually or in facsimile,
and an imprint or facsimile of its corporate seal to be imprinted hereon. 
  

									
	 [FACSIMILE OF SEAL]
	 	 	 	 HEALTH CARE PROPERTY
 INVESTORS, INC.

					
	 	 	 	 	 	 	By:	 	 
	 	 	 	 	 	 	 	 	 Mark Wallace

	 	 	 	 	 	 	 	 	 Senior Vice President and
 Chief Financial Officer

  

			
	Attest:
		
	By:	 	 
	 	 	 Edward J. Henning

	 	 	 Senior Vice President, General
 Counsel and Corporate
Secretary

  
 Dated: August 27, 2004 
  
 CERTIFICATE OF AUTHENTICATION 
 This is one of the Securities of the series 
 designated herein referred to in the 
 within-mentioned Indenture. 
  

			
	 THE BANK OF NEW YORK
   as
Trustee

		
	By:	 	 
	 	 	Authorized Signatory

  

 OPTION TO ELECT REPAYMENT 
  
 The undersigned hereby irrevocably request(s) and instruct(s) the Company to repay this Note (or portion hereof specified
below) pursuant to its terms at a price equal to the principal amount hereof together with interest to the repayment date, to the undersigned, at 
  

  

 (Please print or typewrite name and address of the undersigned) 
  
 For this Note to be repaid, the Trustee must receive at its Corporate Trust Office, or at such other place or places of which the Company shall from time
to time notify the Holder of this Note, not more than 60 nor less than 30 days prior to the Optional Repayment Date, if any, shown on the face of this Note, this Note with this “Option to Elect Repayment” form duly completed. 

 
 If less than the entire principal amount of this Note is to be repaid,
specify the portion hereof (which shall be increments of $1,000) which the Holder elects to have repaid
$                                 and specify the denomination or denominations
(which shall be $1,000 or an integral multiple thereof) of the Notes to be issued to the Holder for the portion of this Note not being repaid (in the absence of any such specification, one such Note will be issued for the portion not being repaid)
$                                . 
  

							
	 Date:
	 	  	 	 	 	  
	 	 	 	 	 	 	The signature on this Option to Elect Repayment must correspond with the name as written upon the face of this Note in every particular, without alteration or enlargement or any change
whatever.

  

	
	Signature Guarantee:
	
	  

  

 ASSIGNMENT/TRANSFER FORM 
  
 FOR VALUE RECEIVED the undersigned registered Holder hereby sell(s), assign(s) and transfer(s) unto (insert Taxpayer
Identification no.)
                                        
                     (Please print or typewrite name and address including postal zip code of assignee)
                        
                                        
                                        
                                        
the within Note and all rights thereunder, hereby irrevocably constituting and appointing
                                       
                                        
                                        
                      attorney to transfer said Note on the books of the Company with full power of substitution in the premises. 

 

									
				
	 Dated:
	 	 	 	 	 	 

  

	NOTICE: 	The signature of the registered Holder on this assignment must correspond with the name as written upon the face of the within instrument in every particular, without alteration or
enlargement or any change whatsoever. 

  

	
	 Signature Guarantee:

	
	  

  

 2 

 ABBREVIATIONS 
  
 The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full
according to applicable laws or regulations. 
  
 TEN COM — as tenants in
common 

									
	UNIF GIFT MIN ACT —	 	
	 	Custodian	 	
	 	 
	 	 	(cust)	 	 	 	(Minor)	 	 
			
	 	 	 Under Uniform Gifts to Minors Act
	 	 
			
	 	 	
	 	 
	 	 	 	 	(State)	 	 	 	 

  
 TEN ENT — as tenants by the
entireties 
 JT TEN — as joint tenants with right of survivorship and not as tenants in common 
  
 Additional abbreviations may also be used though not in the above list.

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]